Mohammadpour Saman, Sadoughi Farahnaz, Arshi Saba, Ayani Shirin, Fallahpour Morteza, Bagherzadeh Rafat
Department of Health Information Management and Technology, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Health Information Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Tanaffos. 2022 Feb;21(2):193-200.
The two main pillars of asthma management include regular follow-up and using guidelines in the treatment process. Patient portals enable regular follow-up of disease, and guideline-based decision-support-systems can improve the use of guidelines in the treatment process. Based on the Global Initiative for Asthma (GINA) and Snell's drug interaction, asthma management system in primary care (AMSPC) includes the capabilities of both mentioned systems. This system was developed to improve regular follow-up and use GINA in the asthma management process. This study aimed to assess the accuracy and usability of the AMSPC based on the GINA and Snell's drug interaction.
To assess the accuracy of the system, kappa test was used to calculate the degree of agreement between the suggestions made by the system and the physician's decision for a total of 64 patients selected through convenience sampling method. To assess usability, the Questionnaire for User Interface Satisfaction (QUIS) was used.
The scores of the Kappa for the agreements between the system and the physician in determining "drug type and dosage", "follow-up time", and "drug interactions" were 0.90, 0.94, and 0.94, respectively. The average score of the QUIS was 8.6 out of 9.
Due to the high accuracy of the system in computerizing the GINA and Snell's drug interaction, as well as its proper usability, it is expected that the system be widely used to improve asthma management and reduce drug interactions.
哮喘管理的两大主要支柱包括定期随访以及在治疗过程中遵循指南。患者门户网站可实现对疾病的定期随访，而基于指南的决策支持系统能够在治疗过程中提高指南的遵循程度。基于全球哮喘防治创议（GINA）和斯内尔药物相互作用，基层医疗中的哮喘管理系统（AMSPC）具备上述两个系统的功能。该系统旨在改善哮喘管理过程中的定期随访并应用GINA。本研究旨在评估基于GINA和斯内尔药物相互作用的AMSPC的准确性和可用性。
为评估该系统的准确性，采用kappa检验计算系统给出的建议与医生决策之间的一致程度，共纳入通过便利抽样法选取的64例患者。为评估可用性，使用了用户界面满意度调查问卷（QUIS）。
在确定“药物类型和剂量”“随访时间”以及“药物相互作用”方面，系统与医生之间的kappa一致性评分分别为0.90、0.94和0.94。QUIS的平均得分为8.6（满分9分）。
由于该系统在将GINA和斯内尔药物相互作用计算机化方面具有较高准确性，且可用性良好，预计该系统将被广泛应用于改善哮喘管理并减少药物相互作用。
